Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone for Opioid-Induced Constipation and Gastrointestinal Stasis in ICU Patients
2014-004687-37Phase 4Completed
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of methylnaltrexone in opioid-induced constipation (OIC) and Gastrointestinal Dysmotility, sponsored by Imperial College Healthcare NHS Trust. Primary endpoint: Time to rescue-free bowel opening. Started Nov 2014; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)Gastrointestinal Dysmotility
Beyond the preview
Go deeper on 2014-004687-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004687-37.